Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IPILIMUMAB for Bone cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where IPILIMUMAB was used for Bone cancer.

Most Reported Side Effects for IPILIMUMAB

Side Effect Reports % Deaths Hosp.
Death 3,710 10.2% 3,709 285
Malignant neoplasm progression 3,296 9.0% 1,570 1,538
Diarrhoea 2,557 7.0% 305 1,643
Off label use 2,097 5.7% 528 731
Colitis 1,988 5.4% 293 1,229
Pyrexia 1,796 4.9% 237 1,336
Rash 1,556 4.3% 162 694
Fatigue 1,447 4.0% 176 776
Intentional product use issue 1,329 3.6% 563 347
Nausea 1,169 3.2% 139 773
Decreased appetite 990 2.7% 136 665
Immune-mediated enterocolitis 988 2.7% 73 504
Hypophysitis 981 2.7% 61 515
Dyspnoea 906 2.5% 165 651
Pneumonitis 891 2.4% 220 560

Other Indications for IPILIMUMAB

Malignant melanoma (8,903) Product used for unknown indication (4,980) Metastatic malignant melanoma (4,430) Non-small cell lung cancer (2,987) Renal cell carcinoma (2,585) Metastatic renal cell carcinoma (1,826) Non-small cell lung cancer recurrent (1,089) Lung neoplasm malignant (530) Small cell lung cancer (474) Pleural mesothelioma malignant (473)

Other Drugs Used for Bone cancer

PALBOCICLIB (493) LENALIDOMIDE (342) CABOZANTINIB S-MALATE (328) DENOSUMAB (219) ENZALUTAMIDE (213) PAZOPANIB (182) ERLOTINIB (174) CAPECITABINE (143) BEVACIZUMAB (140) POMALIDOMIDE (114)

Related Pages

IPILIMUMAB Full Profile All Bone cancer Drugs IPILIMUMAB Demographics IPILIMUMAB Timeline